Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 15


Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer.

Reddy SM, Sadim M, Li J, Yi N, Agarwal S, Mantzoros CS, Kaklamani VG.

Br J Cancer. 2013 Aug 20;109(4):872-81. doi: 10.1038/bjc.2013.441. Epub 2013 Aug 6.


The role of the fat mass and obesity associated gene (FTO) in breast cancer risk.

Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, Tofilon S, Agarwal S, Pasche B, Mantzoros C.

BMC Med Genet. 2011 Apr 13;12:52. doi: 10.1186/1471-2350-12-52.


Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B.

Metabolism. 2011 Sep;60(9):1234-43. doi: 10.1016/j.metabol.2011.01.005. Epub 2011 Mar 12.


Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.

Pasche B, Wisinski KB, Sadim M, Kaklamani V, Pennison MJ, Zeng Q, Bellam N, Zimmerman J, Yi N, Zhang K, Baron J, Stram DO, Hayes MG.

J Exp Clin Cancer Res. 2010 May 25;29:57. doi: 10.1186/1756-9966-29-57.


Tgfbr1 haploinsufficiency inhibits the development of murine mutant Kras-induced pancreatic precancer.

Adrian K, Strouch MJ, Zeng Q, Barron MR, Cheon EC, Honasoge A, Xu Y, Phukan S, Sadim M, Bentrem DJ, Pasche B, Grippo PJ.

Cancer Res. 2009 Dec 15;69(24):9169-74. doi: 10.1158/0008-5472.CAN-09-1705. Epub .


Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development.

Zeng Q, Phukan S, Xu Y, Sadim M, Rosman DS, Pennison M, Liao J, Yang GY, Huang CC, Valle L, Di Cristofano A, de la Chapelle A, Pasche B.

Cancer Res. 2009 Jan 15;69(2):678-86. doi: 10.1158/0008-5472.CAN-08-3980.


Role of polymorphisms in Adamantiades-Beh├žet's disease.

Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B.

J Rheumatol. 2008 Dec;35(12):2376-8. Epub 2008 Oct 15.


Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk.

Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B.

JAMA. 2008 Oct 1;300(13):1523-31. doi: 10.1001/jama.300.13.1523.


Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer.

Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A.

Science. 2008 Sep 5;321(5894):1361-5. doi: 10.1126/science.1159397. Epub 2008 Aug 14.


Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.

Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C.

Cancer Res. 2008 May 1;68(9):3178-84. doi: 10.1158/0008-5472.CAN-08-0533.


Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.

Bian Y, Knobloch TJ, Sadim M, Kaklamani V, Raji A, Yang GY, Weghorst CM, Pasche B.

Hum Mol Genet. 2007 Dec 15;16(24):3128-35. Epub 2007 Sep 21.


Transcriptional regulation of CD4 gene expression by T cell factor-1/beta-catenin pathway.

Huang Z, Xie H, Ioannidis V, Held W, Clevers H, Sadim MS, Sun Z.

J Immunol. 2006 Apr 15;176(8):4880-7.


Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL.

Xie H, Huang Z, Sadim MS, Sun Z.

J Immunol. 2005 Dec 15;175(12):7981-8.


Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells.

Manicassamy S, Sadim M, Ye RD, Sun Z.

J Mol Biol. 2006 Jan 20;355(3):347-59. Epub 2005 Nov 8.


RORgammat recruits steroid receptor coactivators to ensure thymocyte survival.

Xie H, Sadim MS, Sun Z.

J Immunol. 2005 Sep 15;175(6):3800-9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk